Key Findings
The Europe Point of care diagnostic market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 8.67% during the forecast period.

Market Insights
The growing prevalence of chronic and infectious diseases, the rise in the implementation of healthcare reforms, and the rising demand for decentralized chronic and infectious disease testing are primarily driving the market growth.

The economies of the United Kingdom, France, Germany, Spain, Italy, and the Rest of Europe are the major revenue contributors to the Europe market. France is among the biggest consumers of pharmaceutical products in the world and one of the most complex markets to commercialize pharmaceutical products.

Competitive Insights
Abbott, Quest Diagnostics Inc., Chembio Diagnost ICS Systems, Inc., Gene POC, Bio-Rad Laboratories, Inc., Trivitron Healthcare, Cardinal Health Inc., Sight Diagnostics Ltd., Biom?rieux SA, Siemens Healthineers, Trinity Biotech, Becton Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and Ortho Clinical Diagnostics are the major companies operating in the region.